A BioSpace tally indicates recent and planned layoffs from Novo Nordisk, Merck, BMS, Bayer, Pfizer, and Novartis could exceed 39,000 roles worldwide. Cuts span administrative, R&D, and manufacturing sites across New Jersey, Pennsylvania, Washington, Ireland, the U.K., and more.
Companies cite restructuring, cost savings, and portfolio focus as drivers, while continuing to invest in growth areas like obesity, diabetes, AI infrastructure, and select therapeutics.
https://www.biospace.com/job-trends/layoffs-from-just-6-pharmas-could-wipe-out-over-39-000-jobs
- Companies and locations affected: Novo Nordisk - Plainsboro NJ and Denmark, Merck - Rahway NJ and U.K., Bristol Myers Squibb - Lawrenceville NJ, Bayer - Germany, Pfizer - U.S., Ireland, U.K., Novartis - East Hanover NJ and Switzerland